When my neck starts to go from “most-of-the-time annoying” to “sometimes-unbearable-and-blinding,” I take a therapeutic dose of NSAID (800 mg of ibuprofen in my case) and 250 mg of carisoprodol, generic for Soma. This combination of anti-inflammatory with a low-dose muscle relaxer, together with a.
Meanwhile, across town, some child’s dear parent or some parent’s dear child gets sick.
Will the patient be able to get the medicine when her doctor prescribes it? Or will authorities make doctors too afraid to prescribe it? Or will a 3rd party payer – insurance or government – it doesn’t matter which – be able to decide the patient doesn’t need it? Can adult patients be trusted with needed medicines created specifically to help them?
I’m not sure how it could be controversial to treat the suffering of fellow human beings who endure so much through no fault of their own, but I know it needs to be addressed.
Bioavailability of oral carisoprodol 250 and 350 mg and metabolism to meprobamate: A single-dose crossover study. Simon S(1), D'Andrea C(2), Wheeler WJ(2), Sacks H(2). Author information: (1)Private practice, Leawood, Kansas. (2)Meda Pharmaceuticals, Inc., Somerset, New Jersey. BACKGROUND: Carisoprodol is a.
National Library of Medicine 8600 Rockville Pike, Bethesda MD, 20894 USA. National Center for Biotechnology Information, U.S.
Curr Med Res Opin. 2010 Jan;26(1):91-9. doi: 10.1185/ . Randomized, double-blind trial of carisoprodol 250 mg compared with placebo and carisoprodol 350 mg for the treatment of low back spasm. Serfer GT(1), Wheeler WJ, Sacks HJ. Author information: (1)South Florida Clinical Research Center.
In this 1-week double-blind, placebo-controlled, parallel-group multicenter trial, patients 18 to 65 years of age with moderate to severe back spasm were randomly assigned to treatment with carisoprodol 250-mg tablets (n = 264), 350-mg tablets (n = 273), or matching placebo tablets (n = 269) three times daily and at bedtime.
When administered three times daily and at bedtime, carisoprodol 250 mg was as effective as 350 mg three times daily and at bedtime with a lower incidence of adverse events and fewer discontinuations of therapy due to adverse events.
Curr Med Res Opin. 2008 Feb;24(2):551-8. doi: 10.1185/ X261014 . Double-blind, placebo-controlled trial of carisoprodol 250-mg tablets in the treatment of acute lower-back spasm. Ralph L(1), Look M, Wheeler W, Sacks H. Author information: (1)San Diego Sports Medicine and Family Health Center, San Diego.
Qualified patients were randomly assigned to treatment with carisoprodol 250-mg tablets (n = 277) or matching placebo tablets (n = 285). The primary analysis was on study Day 3. Four secondary endpoints were also assessed: (1) the Roland-Morris Disability Questionnaire (RMDQ), (2) time to symptom improvement, (3) patient-rated medication helpfulness, and (4) physician assessment of range of motion. This was a 7-day, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. The coprimary efficacy endpoints were patient-rated global impression of change and patient-rated relief from starting backache scored on a 5-point rating scale.
Patients experienced clinical improvement with or without sedation.
SOMA 250 (Carisoprodol) drug information & product resources from MPR including dosage information, educational materials, & patient assistance.
Company: Mylan Specialty L.P.
Dizziness, drowsiness, headache, GI upset, rash, tachycardia, orthostatic hypotension; rare idiosyncratic reactions (see literature). Tabs—100.
Select the drug indication to add to your list.
Only 4 drugs may be compared at once.
Drug abuse. Pregnancy (Cat.C). Renal or hepatic dysfunction. Nursing mothers.
Sedative effects potentiated by alcohol, other CNS depressants. May be antagonized by CYP2C19 inducers (eg, rifampin, St. John's Wort). May be potentiated by CYP2C19 inhibitors (eg, omeprazole, fluvoxamine). SOMA Muscle relaxant (central).
Relief of acute, painful musculoskeletal conditions.
is for nurse practitioners and physician assistants, offering the latest information on diagnosing, treating, managing, and preventing medical conditions typically seen in the office-based primary-care setting.
Porphyria. ≥16yrs: 250mg–350mg 3 times daily and at bedtime. Max 2–3 weeks. <16yrs: not recommended.
Generic Name and Formulations: Carisoprodol 250mg; tabs.
Find all of the news and departments you love from the print issue archived for easy online access, along with special Web-only content.